Cayman Forensics

With more than 30 years of experience in the synthesis, purification, and characterization of biochemicals, Cayman Chemical has become a leader in the field of designer drugs by providing high-purity reference standards to federally licensed laboratories and qualified academic research institutions for forensic analysis. Our highly trained staff of chemists provide institutions with solutions to quickly identify and understand the physiological and toxicological properties of new designer drugs. Cayman synthesizes a range of analytical standards including synthetic cannabinoids, cathinones, phenethylamines, amphetamines, indanes, opioids, benzodiazepines, tryptamines, and phytocannabinoids, among many others.

For institutions that rely on highly traceable reference standards for use in quantitative or qualitative testing, Cayman offers synthesized reference materials and certified reference materials accredited to meet ISO/IEC 17025:2017 and ISO 17034:2016 guidelines.

Quality and Certifications

We are committed to ensuring and maintaining quality in all aspects of our reference material production.

Our quality management system is implemented and maintained by trained staff to meet the requirements set forth in ISO/IEC 17025 and ISO 17034. This quality management system is applicable to all staff and activities associated with the manufacture and testing of certified reference standards in our ISO-accredited laboratory.

Certificates of Analysis

Each Reference Material (RM) and Certified Reference Material (CRM) is accompanied by an enhanced certificate of analysis (CofA) accredited to ISO standards for testing laboratories and RM producers.

Cayman’s CofA will include a comprehensive table of methods used for the analysis of the neat material, an estimate of uncertainty for each measurement, all relevant analytical data, and a stability assessment.

The CofAs for CRMs additionally report the certified concentration and corrected purity values with the corresponding measurement uncertainties.

View a sample CofA for our certified reference material (PDF)

ISO/IEC 17025:2017

ISO/IEC 17025:2017 meets the general requirements for the competence of testing and calibration laboratories. This ISO standard ensures Cayman is carrying out tests and calibrations to the highest degree of quality and reliability while characterizing RMs and CRMs.

View the ISO/IEC 17025:2017 Certificate and Scope of Accreditation (PDF)

ISO 17034:2016

ISO 17034:2016 meets the general requirements for the competence of RM producers. This ISO standard recognizes Cayman for its competence in carrying out the standardized production, storage, and distribution of CRMs.

View the ISO 17034:2016 Certificate and Scope of Accreditation (PDF)

New Products

Product Search and Drug ID

Product Search +

Search against product name, item number, or CAS number

INSERT SYMBOLS:

• ±
• α
• β
• γ
• δ
• Δ
• ε
• ζ
• κ
• ω
• ö
• ®
• ™
• µ

VIEW ALL (1,500+ PRODUCTS)

Attribute Search +

Type

DEA Schedule

VIEW ALL (1,500+ PRODUCTS)

GC-MS Search Tool +

Identify by formula weight

Identify by base peak ion

Identify by 2nd base peak ion

VIEW ALL (1,500+ PRODUCTS)

Can't find your unknown? Please submit your GC-MS data and any relevant information (suspected chemical class, matrix, solvent, GC parameters, etc.) to techserv@caymanchem.com and our scientists can help you solve your unknown.

 

Product Search Results (Start Your Search Above)

GC-MS Search Tool Results (Start Your Search Above)

Attribute Search Results (Start Your Search Above)

Synthetic Cannabinoid Flipbook

Cayman’s Flipbook tool is a user-friendly application designed for forensic chemists to quickly identify drugs of abuse that share common pharmacophores with scheduled substances. Users of the Flipbook tool must be affiliated with federal, state, or local governments or associated with a recognized research institution.

Launch Flipbook

Cayman Spectral Library (CSL)

The Cayman Spectral Library is a searchable GC-MS spectral database that contains 70eV EI mass spectral data of hundreds of Cayman Chemical's emerging forensic drug standards. This library is being provided as a free service to assist forensic labs in the identification of emerging synthetic drugs of abuse.

Download

You can download the latest Cayman Spectral Library by acknowledging the disclaimer below. You will be required to login or register. This database is available in two formats:

• Agilent MSD ChemStation
• NIST

Log in or Register to download.

Disclaimer

Cayman makes reasonable efforts to include accurate and up-to-date information, however, we make no representations, warranty or guarantee of any kind, whether written or oral, expressed or implied, including without limitation, any warranty of fitness for a particular purpose, the suitability, merchantability, or to the accuracy or completeness of the information contained herein. All users expressly agree that use of this library is at their sole risk.

Indemnification

Cayman, its officers, directors, employees, agents, suppliers will not be liable for any damages of any kind arising from the use of this library or any information contained herein, including, but not limited to direct, indirect, incidental, punitive and consequential damages.

Many of the new products offered at Cayman are a result of requests from customers like you. A complete list of our qualified forensic drug standards can be found on Forensic Science Products. If you are looking for a currently unavailable forensic standard we encourage you to contact our sales or technical staff with your ideas.

Version info/Additions

We can also help with unknown identifications. Email us at techserv@caymanchem.com.

Services

Cayman scientists collaborate with forensic and academic labs to provide data and analytical reference standards to help quickly identify emerging drugs of abuse. With a staff of more than 50 chemists located on a 241,000 ft² campus in Ann Arbor, Michigan, Cayman has the resources and expertise to offer affordable custom services with reasonable pricing and reliable lead times.

Custom Mixtures

Cayman’s custom mixtures provide an accurate and simplified workflow solution for your mass spectrometry (MS) applications.

• Packaged in amber ampules; headspace purged with argon
• Designed for direct snap and inject use in MS applications
• Cost-effective

Analytical Services

Cayman’s analytical team has more than 20 years of experience in analytical chemistry and offers a wide range of services at competitive prices.

• LC-MS/MS quantitative analysis of drugs and metabolites
• Unknown identification via high resolution MS/MS, NMR, and GC-MS
• Analytical support services including MS, NMR, GC-MS, HPLC, optical rotation, and HPLC purification
• ISO/IEC 17025:2017 accredited analytical services

Custom Organic Synthesis

Cayman offers custom synthesis of high-purity reference standards at reasonable prices and rapid delivery. Our scientists will work with each customer to confirm emerging drugs of abuse and their metabolites.

• Competitive pricing
• Rapid turnaround/on-time delivery
• Comprehensive characterization (HPLC, MS, NMR, etc.)
• Deuterium and ¹³C labeling
• Isomer and metabolite synthesis

Publications

Application notes Scientific posters Lab Wall Posters Cayman Currents Brochures Tips for Interpreting GC-MS Fragmentation of Unknown Substituted Fentanyls

See Forensics News & Announcements

Scientific Papers

Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS
Patton, Amy L., Seely, Kathryn A., Pulla, Sharon, Rusch, Nancy J., Moran, Cindy L., Fantegrossi, William E., Knight, Laura D., Marraffa, Jeanna M., Kennedy, Paul D., James, Laura P., Endres, Gregory W., Moran, Jeffery H. Analytical Chemistry. 2014 Feb 4;86(3):1760-6. doi: 10.1021/ac4036197. Epub 2014 Jan 15.

Quantitative Measurement of JWH-018 and JWH-073 Metabolites Excreted in Human Urine
Cindy L. Moran, Vi-Huyen Le, Krishna C. Chimalakonda, Amy L. Smedley, Felisia D. Lackey, Suzanne N. Owen, Paul D. Kennedy, Gregory W. Endres, Fred L. Ciske, James B. Kramer, Andrei M. Kornilov, L. D. Bratton, Paul J. Dobrowolski, William D. Wessinger, William E. Fantegrossi, Paul L. Prather, Laura P. James, Anna Radominska-Pandya, and Jeffery H. Moran, A Major Glucuronidated Metabolite of JWH-018 Is a Neutral Antagonist at CB1 Receptors Kathryn A. Seely, Lisa K. Brents, Anna Radominska-Pandya, Gregory W. Endres, Gregory S. Keyes, Jeffery H. Moran, and Paul L. Prather Chem. Res. Toxicol., 2012, 25 (4), pp 825-827

Cytochrome P450-mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in "K2/Spice": Identification of Novel Cannabinoid Receptor Ligands
Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton, Lisa K. Brents, Cindy L. Moran, Gregory W. Endres, Laura P. James, Paul F. Hollenberg, Paul L. Prather, Anna Radominska-Pandya, Jeffery H. Moran. Drug Metab Dispos. 2012 Nov; 40(11):2174-84. doi: 10.1124/dmd.112.047530. Epub 2012 Aug 17.

Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine
Krishna C. Chimalakonda, Cindy L. Moran, Paul D. Kennedy, Gregory W. Endres, Adam Uzieblo, Paul J. Dobrowolski, Kim E. Fifer, Jeff Lapoint, Lewis S. Nelson, Robert S. Hoffman, Laura P. James, Anna Radominska-Pandya, Jeffery H. Moran Anal Chem. Author manuscript; available in PMC 2012 August 15. Published in final edited form as: Anal Chem. 2011 August 15; 83(16): 6381-6388. Published online 2011 July 27. doi: 10.1021/ac201377m

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity
Lisa K. Brents, Emily E. Reichard, Sarah M. Zimmerman, Jeffery H. Moran, William E. Fantegrossi, Paul L. Prather PLoS One. 2011; 6(7): e21917. Published online 2011 July 6. doi: 10.1371/journal.pone.0021917

Conjugation of Synthetic Cannabinoids JWH-018 and JWH-073, Metabolites by Human UDP-Glucuronosyltransferases
Krishna C. Chimalakonda, Stacie M. Bratton, Vi-Huyen Le, Kan Hui Yiew, Anna Dineva, Cindy L. Moran, Laura P. James, Jeffery H. Moran, Anna Radominska-Pandya Drug Metab Dispos. 2011 October; 39(10): 1967-1976. doi: 10.1124/dmd.111.040709

Forensic investigation of K2, Spice, and 'bath salt' commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds
Seely KA, Patton AL, Moran CL, Womack ML, Prather PL, Fantegrossi WE, Radominska-Pandya A, Endres GW, Channell KB, Smith NH, McCain KR, James LP, Moran JH. Forensic Sci Int. 2013 Dec 10; 233(1-3): 416-22. doi: 10.1016/j.forsciint.2013.10.002. Epub 2013 Oct 14. Forensic Sci Int. 2013 Dec 10; 233(1-3): 10.1016/j.forsciint.2013.10.002. Epub 2013 Oct 14.

Targeted Metabolomic Approach for Assessing Human Synthetic Cannabinoid Exposure and Pharmacology
Amy L. Patton, Kathryn A. Seely, Krishna C. Chimalakonda, Johnny P. Tran, Matthew Trass, Art Miranda, William E. Fantegrossi, Paul D. Kennedy, Paul Dobrowolski, Anna Radominska-Pandya, Keith R. McCain, Laura P. James. Anal. Chem. 2013; 6(7)9390–9399. doi: 10.1021/ac4024704. Epud 2013 Aug 29.

A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors
Seely KA, Brents LK, Radominska-Pandya A, Endres GW, Keyes GS, Moran JH, Prather PL. Chem Res Toxicol. 2012 Apr 16; 25(4): 825-7. doi: 10.1021/tx3000472. Epub 2012 Mar 15.

Quantitation of Synthetic Cannabinoids in Plant Materials Using High Performance Liquid Chromatography with UV Detection (Validated Method)
Ciolino, Laura A. Journal of Forensic Science. 2015 Sept; 60(5):1171-81.doi:10.1111/1556-4029.12795. Epub 2015 Jul 14.

Product Categories

Cayman’s forensic product line is continually evolving. We are dedicated to working with the forensic and academic communities to identify emerging drugs of abuse and to quickly make authentic reference standards available from our ISO/IEC 17025:2017 and ISO 17034:2016 labs.

Fentanyl Analog Screening (FAS) Kit

The Centers for Disease Control and Prevention (CDC) has developed Traceable Opioid Material* Kits to support laboratory detection of current and emerging opioids in the U.S. The CDC has contracted Cayman Chemical to manufacture and distribute the FAS Kit, which is part of the Traceable Opioid Material* Kits product line. The FAS Kit and its expansion pack (Emergent Panel Version 1) contain analog reference materials that will enable labs to screen for 150 synthetic opioid compounds, including more than 140 fentanyl analogs. To view the entire list of compounds included in the kit, please download the compound list (PDF).

Is My Lab Eligible for a Free FAS Kit?

Labs that perform drug testing or analysis may apply for a free FAS Kit if they meet the following requirements:

• Must be located in the U.S. (or a U.S. Territory) with a verifiable business address
• Hold a valid DEA controlled substance registration for Schedule I controlled substances

To start the application process for a new DEA controlled substance registration, go to https://apps.deadiversion.usdoj.gov/webforms/jsp/regapps/common/newAppLogin.jsp.

For additional guidance, contact DEA’s Registration Call Center at 1-800-882-9539 or a local DEA field office. A description of the registration process and a link to DEA’s field office search tool can be found at https://www.deadiversion.usdoj.gov/drugreg/process.htm.

FAS Kit Application

To be considered for a free FAS Kit, please ensure your lab meets the eligibility requirements stated above and completely fill out the application below.

APPLY TODAY

PLEASE COMPLETE ALL FIELDS

First Name:

Last Name:

Institution:

Lab Name:

Address Line 1:

Address Line 2:

City:

State: AL AK AS AZ AR CA CO CT DE DC FM FL GA GU HI ID IL IN IA KS KY LA ME MH MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND MP OH OK OR PW PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY

Zip Code:

Email:

Verify Email:

Telephone:

Quantity Requested:

Does your laboratory have a current DEA registration to handle scheduled substances? Yes No

Which schedules?

I II III IV V

Please enter your DEA license number:

What is your application status: Currently applying Will apply No plans to apply

Which of the following best describes your laboratory? Academic Research Laboratory Environmental Laboratory Government Crime Laboratory Government Toxicology Laboratory Private or Public Clinical Laboratory Other (please specify)

Please briefly describe your laboratory:

Which of the following tests or services are performed by your laboratory? (Select all that apply)

Seized drug sample testing

Post-mortem toxicology sample testing

Workplace drug screening

Newborn drug screening

Drug pharmacology and pharmacokinetics research

Clinical testing for disease diagnosis and treatment or surveillance

Other (please specify)

On average, how many opioid-related samples does your laboratory analyze on a weekly basis? <100 100-500 501-1000 >1000

Which of the following analytical techniques do you perform in your laboratory? (Select all that apply)

Immunoassay

Infrared Spectroscopy

Mass Spectrometry

Nuclear Magnetic Resonance Spectroscopy

Raman Spectroscopy

X-ray Diffraction

Chromatographic Separation

UV/Vis

Other (please specify)

Which matrix type does your laboratory analyze? (Select all that apply)

Blood

Urine

Other (please specify)

What sample sizes are being tested?

<0.1 mL

0.1-0.5 mL

>0.5 mL

Other (please specify)

View our Privacy Statement for details on how we use and protect your data.

Submit